Nové poznatky o patogenezi folikulárního lymfomu a koncepty cílené léčby

Warning

This publication doesn't include Faculty of Medicine. It includes Central European Institute of Technology. Official publication website can be found on muni.cz.

Title in English Novel Findings in Follicular Lymphoma Pathogenesis and the Concepts of Targeted Therapy
Authors

DEVÁN Ján MUSILOVÁ Kateřina JANÍKOVÁ Andrea MRÁZ Marek

Year of publication 2017
Type Article in Periodical
Magazine / Source Klinická onkologie
MU Faculty or unit

Central European Institute of Technology

Citation
Web https://www.linkos.cz/english-summary/klinicka-onkologie-journal/2017-08-15-4-en/novel-findings-in-follicular-lymphoma-pathogenesis-and-the-concepts-of-targeted/
Doi http://dx.doi.org/10.14735/amko2017247
Field Oncology and hematology
Keywords Follicular Lymphoma
Description The molecular pathogenesis of follicular lymphoma (FL) was partially revealed by the discovery of BCL2 translocations to the region encoding the immunoglobulin heavy chain, which accompany the vast majority of cases. This aberration leads to the ectopic and constitutive expression of anti-apoptotic BCL2 protein in B-cells. Nevertheless, the aberration alone is not sufficient for FL development, which suggests necessity of further genetic aberrations acquisition for neoplastic transformation to FL. Their discovery has been enabled by recent progress in the field of massive parallel sequencing (next generation sequencing), which revealed high number of genetic aberrations connected with onset and progression of FL. The occurrence of many of these aberrations in the early stages of the disease, and the fact that they are shared by the majority of patients with FL, fundamentally changed our former understanding of the disease onset. Furthermore, in a large fraction of patients, FL undergoes histological transformation to a more aggressive lymphoma, which is also associated with specific genetic alterations. In this review, we summarize the current knowledge of molecular pathways connected with FL biology and discuss their role in the context of normal B-cell development. Understanding of FL biology is essential for the development of new targeted therapies and the stratification of patients, and potentially also for the selection of treatment for specific patients who share the same genetic aberrations.
Related projects:

You are running an old browser version. We recommend updating your browser to its latest version.

More info